Company Global Bioenergies

Equities

ALGBE

FR0011052257

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Ratings for Global Bioenergies

EPS Revisions

Annual profits - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 16:35:00 26/04/2024 BST			5-day change	1st Jan Change
1.788 ^EUR	+2.17%		-2.83%	-11.49%

04-09	Global Bioenergies Receives EUR70 Million Indicative Orders for New Plant	MT
03-06	Global Bioenergies SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Global Bioenergies substitutes products of fossil origin with products of natural origin. In their quest for naturalness without compromising on performance, the cosmetics players are the Company's first customers. By 2027, Global Bioenergies will be operating its innovative process in a large-scale plant. By 2030, the Company plans to become a leader in the huge emerging market for sustainable aviation fuels, in order to fight against global warming.

Number of employees: 45

EUR in Million	Weight	2023	Weight	Delta
Isobutene 68.7 %	36.2 %	2	68.7 %	+783.58%
Services 27.5 %	43.8 %	1	27.5 %	+192.59%
Ancillary Activities 3.8 %	19.9 %	0	3.8 %	-12.35%

EUR in Million	2022	Weight	2023	Weight	Delta
France 100.0 %	1	100.0 %	3	100.0 %	+365.83%

Managers	Title	Age	Since
Marc Delcourt FOU	Founder	53	05/10/08
Samuel Dubruque DFI	Director of Finance/CFO	-	31/12/13
Frédéric Ollivier CTO	Chief Tech/Sci/R&D Officer	-	31/08/19
Bernard Chaud PRN	Corporate Officer/Principal	-	31/12/14
Alexandra Ramirez Moncada LAW	General Counsel	-	31/12/16
Martin Stephan PRN	Corporate Officer/Principal	-	18/10/23

Members of the board	Title	Age	Since
Pierre Levi BRD	Director/Board Member	69	17/04/19
Marc Delcourt FOU	Founder	53	05/10/08
Jean-Claude Lumaret BRD	Director/Board Member	66	01-17
Marie-Odile Lavenant BRD	Director/Board Member	58	01/06/22
Pierre Monsan BRD	Director/Board Member	75	27/09/21
Muriel Atias BRD	Director/Board Member	-	-
Corinne Granger CHM	Chairman	66	02/11/20

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	11	18,168,892	15,233,947 ( 83.85 %)	7,265 ( 0.0400 %)	83.85 %

Name	Equities	%	Valuation
BOLD Business Opportunities For l'Oréal Development SASU 10.87 %	1,972,206	10.87 %	4 M €
OFI Invest Asset Management SA 2.393 %	434,000	2.393 %	863 382 €
Marc Delcourt 2.097 %	380,342	2.097 %	756 637 €
La Française Asset Management SAS 1.012 %	183,520	1.012 %	365 087 €
DNCA Finance SA 0.9975 %	180,943	0.9975 %	359 961 €
Friedland Gestion SAS 0.3230 %	58,593	0.3230 %	116 563 €
Uzes Gestion SA 0.2205 %	40,000	0.2205 %	79 574 €
GLOBAL BIOENERGIES 0.1075 %	19,496	0.1075 %	38 785 €
NOVACAP Asset Management SA 0.1021 %	18,528	0.1021 %	36 859 €
La Financière Desselligny SA 0.0451 %	8,174	0.0451 %	16 261 €

Name	Equities	%	Valuation
GLOBAL BIOENERGIES 0.11%	19,496	0.11%	38,785 $

Global Bioenergies SA

5, rue Henri Desbruères

91000, Evry

+33 1 64 98 20 50

http://www.global-bioenergies.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.788 EUR

Average target price

2.6 EUR

Spread / Average Target

+45.41%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
GLOBAL BIOENERGIES	-11.49%	34.53M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B

Other Advanced Medical Equipment & Technology